who should not use glp 1 The Science Behind GLP-1 Medications: Facts vs Hype GLP-1 has changed the conversation

In a phase 2 study, amycretin showed a mean weight reduction of up to 24.3%, which is comparable to or even greater than the weight loss seen with tirzepatide and similar to the results for retatrutide

Explore realistic results and sustainable progress.

Using health record data, the research team tracked more than 42,000 adults already taking at least two types of blood pressure medications

Understanding these foods helps maximize weight loss results whether you use lifestyle changes alone or combine them with compounded semaglutide therapy

05, 2025 (GLOBE NEWSWIRE) -- Weight loss is more than calories in versus calories outits a battle that often begins in the gut

This article examines the growing prevalence of pediatric obesity and its connection to metabolic dysfunction-associated steatotic liver disease (MASLD) in children and adolescents, focusing on the role of glucagon-like peptide-1 receptor agonists ...